spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  New Enterprise Associates 

 HSMN NewsFeed - 11 Jun 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 23 Jul 2024
Magenta Medical Closes $105M Financing Led by Novo Holdings
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 6 Sep 2023
OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jun 2023
Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Dec 2021
Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 May 2020
ChromaCode Raises $10 Million Series C Financing From Adjuvant Capital
Diagnostics Venture Capital
 HSMN NewsFeed - 19 May 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Dec 2019
ChromaCode Raises $28 Million in Series C Financing
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 5 Dec 2019
Black Diamond Therapeutics Closes $85 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 20 May 2019
Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Apr 2019
Intrinsic Therapeutics Completes $52m Financing to Fuel Commercial Efforts in the United States to Benefit Lumbar Discectomy Patients
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 13 Feb 2019
Alan M. Muney, MD, MHA Joins NEA As Venture Advisor
Devices Venture Capital Personnel
 HSMN NewsFeed - 26 Jun 2018
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 25 Apr 2018
FDA Grants Fast Track Designation for OrphoMed's ORP-101 for Treatment of IBS-D
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 23 Apr 2018
OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 27 Feb 2018
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jan 2018
Personal Genome Diagnostics Raises $75 Million to Bring Regulated IVD Genomic Tests to Cancer Patients Worldwide
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 7 Dec 2017
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Aug 2017
Amplyx Pharmaceuticals Raises $67 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jan 2017
Vtesse Announces Appointment of Jason Meyenburg as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2016
Moximed: First Patient Treated in US Study of Atlas(R) System for Unicompartmental Knee Osteoarthritis
Devices Orthopaedic
 HSMN NewsFeed - 9 Aug 2016
CVRx(R) Secures $113 Million in New Financing
Devices Venture Capital
 HSMN NewsFeed - 29 Jul 2016
VytronUS, Inc. Raises $49 Million in Series C Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 15 Jul 2016
Ardelyx to Raise $110 Million in a Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Nov 2015
ObsEva Closes CHF 60 (USD 60) Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Nov 2015
Moximed Announces CE Mark and First Commercial Use of Atlas(TM) Knee System
Devices Orthopaedic Regulatory Product Launch
 HSMN NewsFeed - 11 Nov 2015
Amplyx Pharmaceuticals Secures $40.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Nov 2015
Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 28 Oct 2015
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates
Diagnostics Oncology Venture Capital Personnel
 HSMN NewsFeed - 26 Oct 2015
Cardionomic Raises $20 Million in Series A Financing to Develop Heart Failure Therapy
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 22 Oct 2015
Vtesse, Inc. Expands Scientific Advisory Board and Appoints New VP of Clinical Operations to Support Late-Stage Clinical Study of Lead Drug Candidate VTS-270
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2015
Galera Therapeutics Raises $37 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 6 Jul 2015
Allergan to Acquire Oculeve Dry Eye Disease Development Programs
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 11 Jun 2015
XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Jun 2015
Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 May 2015
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2015
Cortendo AB: Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing
Biopharmaceuticals Acquisitions Licensing Venture Capital
 HSMN NewsFeed - 11 May 2015
Cartiva, Inc. Closes $8.5 Million Financing
Devices Venture Capital Personnel
 HSMN NewsFeed - 6 Apr 2015
VytronUS, Inc. Attracts Industry Veteran John Pavlidis as New President and Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 7 Jan 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin(TM) Platform for Cancer Therapeutics
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 23 Sep 2014
Ivantis Raises Additional $25 MM, Increasing Series B to $71 MM
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 19 Aug 2014
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
Biopharmaceuticals Dermatology Venture Capital Personnel
 HSMN NewsFeed - 22 Jul 2014
Synlogic Secures $29.4 Million Series A Financing Led by Atlas Venture and New Enterprise Associates
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jun 2014
Solace Therapeutics Receives Two FDA Clearances towards Providing Women an Office-Based Treatment for Stress Urinary Incontinence (SUI).
Devices Urology FDA
 HSMN NewsFeed - 5 Jun 2014
Senseonics Raises $20 Million
Devices Monitoring Endocrinology Personnel
 HSMN NewsFeed - 19 Mar 2014
Mirna Therapeutics Appoints Casi DeYoung as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Mar 2014
Lumena Pharmaceuticals Raises $45 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jan 2014
Covidien, Lightstone Ventures, New Enterprise Associates Announce Series A Investment in FIRE1
Devices Venture Capital Personnel
 HSMN NewsFeed - 2 Jan 2014
Marina Biotech and Mirna Therapeutics Amend License Agreement for the Development of microRNA-Based Therapeutics
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 12 Nov 2013
Envisia Therapeutics Debuts with $25 Million Series A Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 8 Oct 2013
Moximed Initiates Study in UK of KineSpring(R) System in Patients with Knee Osteoarthritis
Devices Orthopaedic
 HSMN NewsFeed - 17 Sep 2013
Solace Therapeutics Adds New Member to Board of Directors
Devices Urology Personnel
 HSMN NewsFeed - 11 Sep 2013
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2013
Edimer Secures $18M Series B Financing Led by New Enterprise Associates
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Jun 2013
3-V Biosciences Completes $20 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Apr 2013
Carticept(R) Medical Receives 510(k) Clearance for Second Generation Navigator(R) Delivery System
Devices Drug Delivery FDA
 HSMN NewsFeed - 15 Apr 2013
Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 18 Dec 2012
Blend Therapeutics Closes $16 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Dec 2012
Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2012
Galera Therapeutics Raises $11 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 27 Nov 2012
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Oct 2012
Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 11 Oct 2012
Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2012
Moximed's Implantable Knee Spring Successfully Reduces Pain and Quickly Returns Normal Function to Osteoarthritis Patients
Devices Orthopaedic
 HSMN NewsFeed - 19 Sep 2012
Boston Scientific to Acquire BridgePoint Medical, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 23 Feb 2012
Satori Pharmaceuticals Raises $15M in New Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jan 2012
Carticept Medical(TM) Closes $10 Million Series C Financing Round
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 1 Nov 2011
Sensors for Medicine and Science Raises $54.1 Million Series D Financing
Devices Monitoring Venture Capital
 HSMN NewsFeed - 21 Jul 2011
Aegerion Pharmaceuticals Announces Appointment of Paul G. Thomas to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2011
Carticept Medical(TM) Receives 510(k) Clearance for Navigator(TM) Delivery System
Devices Drug Delivery FDA
 HSMN NewsFeed - 27 Jun 2011
Ivantis Announces Completion of $17 MM Financing, CE Mark Approval, and Initiation of International Randomized Controlled Trial for Revolutionary Glaucoma Procedure
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 21 Jun 2011
TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 May 2011
BridgePoint Medical Announced 510(k) Clearance for an Expanded Indication to Treat Coronary Chronic Total Occlusions
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Feb 2011
3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2011
Ulthera Announces $10.5 Million in Series C Venture Capital Funding
Devices Venture Capital
 HSMN NewsFeed - 2 Feb 2011
Spine Wave Announces Completion of $17.5M Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 1 Feb 2011
VertiFlex(R), Inc. Announces Financing and New Investment Partner
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 7 Jan 2011
23andMe Announces Additional Investment in Series C Financing; Dr. Ashley Ledbetter Dombkowski of MPM Capital Joins 23andMe's Board of Directors
Personalized Medicine Venture Capital Personnel
 HSMN NewsFeed - 2 Dec 2010
PhaseBio Pharmaceuticals Reaches Key Milestones and Receives $15 Million to Complete Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Sep 2010
Zyngenia, Inc. Raises $15 Million in Series A Extension Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Sep 2010
Rhythm Closes $40 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jul 2010
Trevena Secures $35 Million in Series B Funding to Progress Portfolio of GPCR Biased Ligands and to Complete Phase 2 Study of TRV120027 for Acute Heart Failure
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jun 2010
Predictive Biosciences Closes $25 Million Series C Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 3 Jun 2010
Anulex Technologies, Inc. to Raise a Minimum of $20 Million in Series E Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 3 Jun 2010
3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2010
Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
Devices Neurology Personnel
 HSMN NewsFeed - 26 May 2010
Tesaro, Inc. Secures $60 Million in Start-up Funding
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 19 May 2010
Spiration Announces Positive Results of European Study Evaluating Safety and Effectiveness of Bronchial Valve Treatment for Severe Emphysema
Devices
 HSMN NewsFeed - 26 Apr 2010
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jan 2010
Liquidia Technologies Raises $20 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Dec 2009
Epizyme Closes $40M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Dec 2009
Apnex Medical, Inc. Raises Additional $14 Million
Devices Venture Capital
 HSMN NewsFeed - 23 Nov 2009
BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 10 Sep 2009
Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 3 Aug 2009
CMS Approves New Technology Add-On Payment for Spiration(R) IBV Valve System
Devices Reimbursement
 HSMN NewsFeed - 21 May 2009
Clovis Oncology Raises $145 Million in Start-Up Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Mar 2009
BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss and Stingray Devices in CTO Angioplasty Procedure
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jan 2009
Acclarent, Inc. Closes $26 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 8 Jan 2009
Concentric Medical Closes on $15 Million Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 8 Jan 2009
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 24 Oct 2008
Spiration, Inc. Receives First FDA Approval for Bronchial Valve
Devices FDA
 HSMN NewsFeed - 16 Oct 2008
Predictive Biosciences Closes $21.75 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 8 Oct 2008
Spiration, Inc. Announces European Launch of Minimally Invasive Pulmonary Device
Devices
 HSMN NewsFeed - 29 Sep 2008
Oceana Therapeutics Commences Operations after Completing Series A Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Sep 2008
VertiFlex Strengthens its Executive Management Team
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 8 Sep 2008
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Aug 2008
Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jul 2008
CVRx(R), Inc. Closes $84 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 16 Jul 2008
Peptimmune Announces the Second Close of Series D Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 May 2008
Olympus Medical Systems Corp. and Spiration, Inc. Sign Agreement to Market and Distribute Minimally Invasive Pulmonary Device in 43 European Countries
Devices Distribution
 HSMN NewsFeed - 14 May 2008
Carticept Medical Reports First Patients Treated in Pivotal Study of Agilus(TM) Therapy for Pain Associated with Ankle Osteoarthritis
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 7 Apr 2008
TargetRx Completes $9.6M Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Mar 2008
MPM Capital and NEA Lead $65 million Series A Preferred Round to Finance Spinout of TriVascular from Boston Scientific
Devices Interventional Venture Capital
 HSMN NewsFeed - 5 Mar 2008
Trevena, Inc. Announces $24 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Feb 2008
DaVita Announces Chief Financial Officer
Personnel
 HSMN NewsFeed - 17 Jan 2008
Ulthera Receives $22.5 Million in Series B Round
Devices Venture Capital
 HSMN NewsFeed - 17 Jan 2008
Peptimmune Announces First Close of Series D Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Jan 2008
Pharmos Corporation Announces Board and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Nov 2007
Evalve(R) Completes $60 Million Series D Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 15 Nov 2007
Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Nov 2007
NEA Completes Investment in Novalar Pharmaceuticals
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Nov 2007
Novalar Raises $30 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Sep 2007
Spiration, Inc. Announces First Patient Enrollment in U.S. Pivotal Trial of Minimally Invasive Treatment for Severe Emphysema
Devices
 HSMN NewsFeed - 19 Sep 2007
Spiration Inc. Announces Positive Results from Pilot Study of Treatment for Patients with Severe Emphysema at European Respiratory Society's Annual Congress
Devices
 HSMN NewsFeed - 19 Sep 2007
Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Sep 2007
NEA Participates in $40M Investment in Hyperion Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Aug 2007
Carticept Medical Expands Management Team with Appointment of Chris Fair to Vice President, Sales and Marketing
Devices Orthopaedic Personnel
 HSMN NewsFeed - 31 May 2007
Macroflux Names M. Cory Zwerling President, CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2007
New Way to Use High Resolution CT Scan Shows Mechanism of Bronchial Valve Treatment in Patients with Severe Emphysema
Devices
 HSMN NewsFeed - 17 May 2007
CVRx(R), Inc. Appoints Todd Langevin Senior Vice President of Clinical and Commercial Development
Devices Personnel
 HSMN NewsFeed - 14 May 2007
APNEX Medical, Inc. Raises $16.1 Million in Series 'A' Financing
Devices Venture Capital
 HSMN NewsFeed - 9 May 2007
Spiration, Inc. Names Nancy Hill Vice President, Marketing to Strengthen Market Development and Global Product Commercialization Initiatives
Devices Personnel
 HSMN NewsFeed - 10 Apr 2007
Spine Wave Closes $45 Million Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 19 Mar 2007
Milestone Scientific Signs Agreement With Carticept Medical to Collaborate on CompuFlo(TM) Injection System for Treatment of Arthritic Joints
Devices Drug Delivery
 HSMN NewsFeed - 6 Mar 2007
TransOral Pharmaceuticals Raises $40 Million in Series D Financing. Proceeds Will Be Used to Complete Intermezzo(TM) Phase 3 Clinical Trials and File NDA
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Jan 2007
BridgePoint Medical, Inc. Raises $10 Million in Series B Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 6 Dec 2006
Cardioxyl Pharmaceuticals Closes $14.5M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Oct 2006
Pharmos Shareholders Approve Vela Pharmaceuticals Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Sep 2006
Amicus Therapeutics Raises $60 Million Series D Financing; Company Also Makes Two Key Executive Appointments
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 May 2006
Esprit Pharma Acquires Exclusive North American Rights to a Novel Treatment for Hypoactive Sexual Desire Disorder in Women from Novavax
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 May 2006
Esprit Pharma Appoints Vice President of Trade
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2006
YM Biosciences completes acquisition of Eximias
Biopharmaceuticals Oncology Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 34

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 34 additional stories matching:
New Enterprise Associates
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!